ORTEXORTEX News
Tracking NPB? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NP
Earnings PreviewNPB

NPB Falls Further Below CEO's Buy Price as Q3 Results Land

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 22 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

NPB has now reported Q3 results, and the stock closed Wednesday at $15.13, down another 4.1% on the day and extending its decline to 8% over the past month. That leaves it roughly 10% below the prices Chairman and CEO Charles Williams paid in late August and early September, a gap that has widened since yesterday's trader note flagged it as the most consequential signal heading into the print.

The CEO's buying remains the defining fact in the file. Williams made three discretionary open-market purchases, none under a 10b5-1 plan, spending approximately $2.75 million at prices between $16.74 and $16.95. The 90-day insider net across all insiders runs to roughly 145,000 shares bought for $2.4 million. Director David Hooker's sales, conducted entirely under a pre-arranged plan and modest in size, carry no comparable conviction read. The CEO bought aggressively into weakness and the market has now moved further against that position.

Analysts remain constructive but have been steadily trimming their ambitions. Piper Sandler held its Overweight rating earlier this month while cutting its target from $21.50 to $20.00. Keefe, Bruyette & Woods made a similar move after the July print, staying at Outperform but stepping down to $21.00. The consensus target of $19.05 implies roughly 26% upside from Wednesday's close. Bulls point to the bank's warehouse lending growth and mortgage origination trajectory, with loan balances projected to reach $3.3 billion to $3.5 billion by year-end. Bears counter that heavy reliance on residential mortgage origination and secondary-market loan sales leaves earnings exposed to rate and liquidity cycles, with credit quality in the advance program an additional variable.

Positioning in the borrow market offers no amplifying pressure either way. Short interest is just 2.1% of free float, down 5% over the past week, and availability is extraordinarily loose at nearly 2,828% of current short interest, meaning the lending pool is almost entirely untapped. Borrowing costs have eased to 0.58% after a brief spike earlier in October. Nothing in the lending market suggests a forced short-covering dynamic or heightened bearish conviction.

The company's own FDIC call report data, published by the Federal Deposit Insurance Corporation, shows total assets and net loans and leases each rising for six consecutive quarters, reaching $7.5 billion and $6.8 billion respectively as of the April 2026 period. The dataset's lead status against the company's reported figures remains untested due to limited history, so it cannot be read as predictive of the print, but the streak in underlying balance sheet growth provides context for how the bank has been expanding.

The Q3 print will test whether Northpointe's mortgage franchise is delivering enough earnings momentum to justify the CEO's conviction buys, and whether the widening gap between insider cost basis and market price starts to narrow.

Stocks in this article

See the live data behind this article on ORTEX.

Open NPB on ORTEX →

How this article was generated

Generated
22 Oct 2026, 04:25
Data as of
22 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.